- -5%
PURPOSE. POSSIBILITY. PROGRESS.
Research peptide
Certificate of Analysis (COA)
Disclaimer
Delivery & Returns
Secure Payments
💉 T2 — Research Peptide
T2 is a synthetic research peptide developed as a dual GIP and GLP-1 receptor agonist, studied for its potential role in glucose metabolism, weight regulation, and metabolic optimization.
Research Focus & Mechanism
• Dual receptor activation:
o GIP (Glucose-Dependent Insulinotropic Polypeptide): Investigated for enhancing insulin sensitivity and fat metabolism
o GLP-1 (Glucagon-Like Peptide-1): Studied for slowing gastric emptying, reducing appetite, and supporting glycemic control
• Together, these pathways are explored for their synergistic effects on metabolic regulation, body composition, and energy balance
Research Insights
• Preclinical and clinical research shows T2 may significantly improve glucose tolerance and reduce body fat mass
• Studied for potential benefits in obesity, insulin resistance, and cardiovascular health research models
• Demonstrated enhanced weight reduction and metabolic efficiency compared to single-agonist peptides like semaglutide
Potential Research Applications
• Metabolic optimization and weight management models
• Glucose and insulin regulation research
• Peptide synergy studies with compounds like AOD-9604, Cagrilintide, or Retatrutide
⚠️ Disclaimer:
T2 is intended for laboratory research purposes only.
It is not approved for human use, consumption, or medical treatment.